Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report

Diabet Med. 2010 Apr;27(4):486-7. doi: 10.1111/j.1464-5491.2010.02973.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angioedema / chemically induced*
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Biphenyl Compounds / adverse effects
  • Biphenyl Compounds / therapeutic use
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use
  • Female
  • Humans
  • Irbesartan
  • Pyrazines / adverse effects*
  • Pyrazines / therapeutic use
  • Sitagliptin Phosphate
  • Tetrazoles / adverse effects
  • Tetrazoles / therapeutic use
  • Treatment Outcome
  • Triazoles / adverse effects*
  • Triazoles / therapeutic use

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Biphenyl Compounds
  • Dipeptidyl-Peptidase IV Inhibitors
  • Pyrazines
  • Tetrazoles
  • Triazoles
  • Irbesartan
  • Sitagliptin Phosphate